Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Initial immunochemical characterization of specific macrophage-arming factor.

R A De Weger1, R J Vandebriel, H Slager

  • 1Department of Experimental Pathology, University of Utrecht, The Netherlands.

Cancer Immunology, Immunotherapy : CII
|January 1, 1989
PubMed
Summary

This study characterizes the specific macrophage-arming factor (SMAF), a T-cell protein that enhances macrophage cytotoxicity against tumors. SMAF exhibits antigen specificity, distinguishing it from antibodies.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Clinical versus histological grading in the assessment of cutaneous graft versus host disease.

European journal of medical research·2019
Same author

Presence of pesticide residues on produce cultivated in Suriname.

Environmental monitoring and assessment·2017
Same author

Imatinib treatment of poor prognosis mesenchymal-type primary colon cancer: a proof-of-concept study in the preoperative window period (ImPACCT).

BMC cancer·2017
Same author

Donor-Specific Antibodies Are Produced Locally in Ectopic Lymphoid Structures in Cardiac Allografts.

American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons·2016
Same author

Comparison of intramedullary myeloma and corresponding extramedullary soft tissue plasmacytomas using genetic mutational panel analyses.

Blood cancer journal·2016
Same author

Higher numbers of memory B-cells and Th2-cytokine skewing in high responders to hepatitis B vaccination.

Vaccine·2016

Area of Science:

  • Immunology
  • Cell Biology
  • Cancer Research

Background:

  • Macrophage-arming factor (SMAF) is released by T lymphocytes upon antigen exposure.
  • SMAF confers specific cytotoxic properties to macrophages.

Purpose of the Study:

  • To immunochemically characterize SMAF.
  • To determine the nature and specificity of SMAF.

Main Methods:

  • Gel filtration to determine molecular mass.
  • Affinity chromatography using monoclonal antibodies and tumor cell membranes.
  • Analysis of antigen-specific binding and elution.

Main Results:

  • SMAF has a molecular mass of 65-85 kDa.
  • SMAF is not an immunoglobulin; it binds to a monoclonal antibody against T-cell factors.

Related Experiment Videos

  • SMAF specifically binds to tumor cell membranes.

    • Conclusions:

    • SMAF is a T-cell factor, not an antibody.
    • SMAF possesses an antigen-specific recognition site.
    • SMAF's specificity is H-2 directed in allogeneic systems and tumor-specific in syngeneic systems.